Company news
TransMedics Group, Inc. news in 2022
TransMedics Group, Inc.'s news releases, calls and decks from 2022, newest first.
TransMedics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 20, 2022
TransMedics Reports Third Quarter 2022 Financial Results
November 2, 2022
TransMedics to Report Third Quarter 2022 Financial Results on November 3, 2022
October 19, 2022
TransMedics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 28, 2022
TransMedics Announces Upsize and Pricing of Public Offering of Common Stock
August 3, 2022
TransMedics Announces Proposed Public Offering of Common Stock
August 2, 2022
TransMedics Reports Second Quarter 2022 Financial Results
July 31, 2022
TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference
July 25, 2022
TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022
July 17, 2022
TransMedics Reports First Quarter 2022 Financial Results
May 2, 2022
TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication
April 27, 2022
TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022
April 18, 2022
TransMedics Announces the Presentation of New OCS™ Heart and OCS™ Lung Clinical Data at the International Society of Heart and Lung Transplantation 2022 Annual Meeting
April 18, 2022
TransMedics to Present at the Oppenheimer's 32nd Annual Healthcare Conference
February 28, 2022
TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results
February 22, 2022
TransMedics to Present at the Cowen 42nd Annual Healthcare Conference
February 21, 2022
TransMedics to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 8, 2022
TransMedics Announces Publication of OCS™ Liver PROTECT Trial Results in JAMA Surgery
January 4, 2022